November 15, 2019 / 12:25 PM / 24 days ago

BRIEF-CHMP Recommends EU Approval Of Roche's Kadcyla For Certain Early Breast Cancer Cases

Nov 15 (Reuters) - Roche Holding AG:

* CHMP RECOMMENDS EU APPROVAL OF ROCHE’S KADCYLA FOR THE ADJUVANT TREATMENT OF PEOPLE WITH HER2-POSITIVE EARLY BREAST CANCER WITH RESIDUAL INVASIVE DISEASE AFTER NEOADJUVANT TREATMENT Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below